UB Ventures

UB Ventures operates as a specialized venture capital firm, funding early-stage breakthrough innovations in oncology. It provides capital, strategic mentorship, operational expertise, and industry connections, aiming to transform peer-reviewed science into market-ready therapies. The firm employs an agile, data-driven approach and a comprehensive platform to navigate R&D complexities.

Established in 2012, UB Ventures was founded on the insight that emerging oncology companies require targeted investment and guidance. The firm addresses unique challenges faced by visionary teams developing nascent solutions, providing crucial initial funding to bridge discovery and commercialization. This commitment empowers groundbreaking medical advancements.

The firm's primary clients are visionary teams developing novel oncology solutions, often receiving crucial first capital. These early-stage companies benefit from UB Ventures' industry knowledge and network, accelerating their market journey. The firm's vision is to drive advancements in cancer care through strategic investments, ultimately delivering life-changing therapies to patients globally.